News
A new combination vaccine could simplify protection against two major respiratory illnesses for older adults, according to a ...
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...
2h
News-Medical.Net on MSNNasal vaccine boosters can trigger strong immune defenses in the respiratory tract, study findsMost vaccines — and boosters — are injected directly into muscle tissue, usually in the upper arm, to kickstart the body's immune system in the fight against disease.
Moderna’s combined Covid and flu shot outperformed the existing standalone vaccines for both viruses, according to the ...
The plans amount to an extraordinary flex of Robert F. Kennedy Jr.’s power as health secretary to make decisions ordinarily ...
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
2d
News-Medical.Net on MSNNew AI tool predicts viral mutations to help future-proof COVID vaccinesA novel AI-driven method helps scientists stay ahead of viral evolution by engineering synthetic spike proteins that ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...
Senior leaders at the US Food and Drug Administration began pushing Moderna Inc. and Pfizer Inc. to file for full, formal ...
The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results